A Vaccine Worth Taking

Jul 1, 1999 5:00 AMNov 12, 2019 4:21 AM

Newsletter

Sign up for our email newsletter for the latest science news
 

Like fatty foods? Worry about cholesterol? No problem, if researchers at Avant Immunotherapeutics Inc. in Needham, Massachusetts, have their way with a vaccine designed to stop the body from converting good cholesterol (HDL) into bad (LDL).

The body normally changes HDL to LDL, so Avant researchers decided that derailing that conversion would head off cholesterol problems at the pass. Using the human immune system as an ally, scientists attached a tetanus toxin to a protein necessary for HDL's transformation to LDL, and injected it into rabbits fed a high-fat diet. The immune system's assault on the targeted protein blocked the conversion. Levels of good cholesterol skyrocketed; levels of bad dropped.

The worry is that the protein might be essential to other important functions in the body. But a group of Japanese with a genetic mutation that blocks cholesterol conversion, mimicking the vaccine's effect, live well into their eighties with healthy hearts. Human trials begin this summer.

1 free article left
Want More? Get unlimited access for as low as $1.99/month

Already a subscriber?

Register or Log In

1 free articleSubscribe
Discover Magazine Logo
Want more?

Keep reading for as low as $1.99!

Subscribe

Already a subscriber?

Register or Log In

More From Discover
Stay Curious
Join
Our List

Sign up for our weekly science updates.

 
Subscribe
To The Magazine

Save up to 40% off the cover price when you subscribe to Discover magazine.

Copyright © 2024 LabX Media Group